TP73 and glioblastoma: TP73-AS1 depletion in a CRISPR/Cas9 dependent manner attenuated stemness capacity in terms of self-renewal and sphere formation and enhanced the sensitivity of glioblastoma cancer stem cells to TMZ [99].